Can an international patient with relapsed B-ALL access CAR-T therapy in China?

Eligibility depends on the patient's leukemia subtype, current disease status, prior treatments, laboratory results, and the specific CAR-T program available at the treating hospital. An individual specialist assessment is required before treatment can be planned.

Can CAR-T therapy be followed by a stem cell transplant for relapsed leukemia?

In some cases, CAR-T therapy can be used to bring relapsed leukemia under better disease control before proceeding to allogeneic stem cell transplantation. Whether this approach is appropriate depends on the patient's response, overall condition, donor availability, and transplant assessment.

How can a Pakistani patient arrange leukemia treatment in China?

The process typically begins with a remote review of medical records, pathology, bone marrow results, treatment history, and current disease status. ChinaCureLink can coordinate the medical review, specialist matching, hospital communication, treatment scheduling, and travel-related logistics for patients accepted for treatment.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

10/10 HLA Match: How CAR-T and Stem Cell Transplant Treated Relapsed B-ALL for a Pakistani Child in China

ChinaCureLink

Thu Sep 10 2026

7 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page